Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis

Journal of Infection

Volumn 68, Issue 1, 2014, Pages 85-89

  Varon, Andrea G ^a   Nouer, Simone A ^a   Barreiros, Gloria ^a   Trope, Beatriz Moritz ^a   Magalhães, Fabiana ^a   Akiti, Tiyomi ^a   Garnica, Marcia ^a   Nucci, Marcio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Fusariosis; Hematologic disease; Invasive fungal disease; Onychomycosis; Risk factor

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONGENITAL SKIN DISEASE; DISEASE ASSOCIATION; FEMALE; FUNGAL COLONIZATION; FUSARIOSIS; FUSARIUM; HALLUX; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTERTRIGO; INVASIVE FUSARIOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONYCHOMYCOSIS; PARONYCHIA; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; SKIN CULTURE; SKIN DEFECT; SYSTEMIC MYCOSIS; THUMB; YOUNG ADULT;

FUSARIOSIS; HEMATOLOGIC DISEASE; INVASIVE FUNGAL DISEASE; ONYCHOMYCOSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; FEMALE; FUSARIOSIS; FUSARIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SKIN; YOUNG ADULT;

EID: 84888861957     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.08.011     Document Type: Article

References (22)

1. Nucci M., Anaissie E.J., Queiroz-Telles F., Martins C.A., Trabasso P., Solza C., et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003, 98:315-319.
2. Nucci M., Marr K.A., Queiroz-Telles F., Martins C.A., Trabasso P., Costa S., et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004, 38:1237-1242.
3. Campo M., Lewis R.E., Kontoyiannis D.P. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect 2010 May, 60:331-337.
4. Nucci M., Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007, 20:695-704.
5. Boutati E.I., Anaissie E.J. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997, 90:999-1008.
6. Nucci M., Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002, 35:909-920.
7. Nucci M., Varon A., Garnica M., Akiti T., Barreiros G., Trope B.M., et al. Increased incidence of invasive fusariosis with a cutaneous portal of entry. Emerg Infect Dis 2013, 19. http://dx.doi.org/10.3201/eid1910.120847.
8. Scheel C.M., Hurst S.F., Barreiros G., Akiti T., Nucci M., Balajee S.A. Molecular analyses of Fusarium isolates recovered from a cluster of invasive mold infections in a Brazilian hospital. BMC Infect Dis 2013, 13:49.
9. de Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
10. Khalil G.M., Al Shobaili H.A., Alzolibani A., Al R.A. Relationship between obesity and other risk factors and skin disease among adult Saudi population. J Egypt Public Health Assoc 2011, 86:56-62.
11. Komba E.V., Mgonda Y.M. The spectrum of dermatological disorders among primary school children in Dar es Salaam. BMC Public Health 2010, 10:765.
12. Nishimoto K. An epidemiological survey of dermatomycoses in Japan, 2002. Nihon Ishinkin Gakkai Zasshi 2006, 47:103-111.
13. Thomas J., Jacobson G.A., Narkowicz C.K., Peterson G.M., Burnet H., Sharpe C. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther 2010, 35:497-519.
14. Karaca S., Kulac M., Cetinkaya Z., Demirel R. Etiology of foot intertrigo in the District of Afyonkarahisar, Turkey: a bacteriologic and mycologic study. J Am Podiatr Med Assoc 2008, 98:42-44.
15. Baudraz-Rosselet F., Ruffieux C., Lurati M., Bontems O., Monod M. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents. Dermatology 2010, 220:164-168.
16. Godoy-Martinez P., Nunes F.G., Tomimori-Yamashita J., Urrutia M., Zaror L., Silva V., et al. Onychomycosis in Sao Paulo, Brazil. Mycopathologia 2009, 168:111-116.
17. Ranawaka R.R., de S.N., Ragunathan R.W. Non-dermatophyte mold onychomycosis in Sri Lanka. Dermatol Online J 2012, 18:7.
18. Escobar M.L., Carmona-Fonseca J. Onychomycosis by common non-dermatophyte moulds. Rev Iberoam Micol 2003, 20:6-10.
19. Pagano L., Caira M., Candoni A., Offidani M., Fianchi L., Martino B., et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006, 91:1068-1075.
20. Pagano L., Caira M., Nosari A., Van Lint M.T., Candoni A., Offidani M., et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007, 45:1161-1170.
21. Nucci M., Garnica M., Gloria A.B., Lehugeur D.S., Dias V.C., Palma L.C., et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 2013, 19:745-751.
22. Grover C., Khurana A. An update on treatment of onychomycosis. Mycoses 2012, 55:541-551.